Anticancer Drugs Oncology Pharmacology Physiotherapy Ribociclib


In this article we will discuss Ribociclib (Dosage Overview)

In this article, we will discuss Ribociclib (Dosage Overview). So, let’s get started.


Ribociclib is indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.


Dosing and Administration

The recommended dose of Ribociclib is 600 mg (three 200 mg film-coated tablets) taken orally, once daily for 21 consecutive days followed by 7 days off treatment resulting in a complete cycle of 28 days. Ribociclib can be taken with or without food.

Coadminister Ribociclib with letrozole 2.5 mg taken once daily throughout the 28-day cycle.

Patients should take their dose of Ribociclib and letrozole at approximately the same time each day, preferably in the morning.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.